{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:49:48Z","timestamp":1790300988972,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["202203021221022"],"award-info":[{"award-number":["202203021221022"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>MicroRNA-34a (miR-34a) was closely associated with liver steatosis. However, the link between changes in miR-34a and the progression of liver steatosis remained unclear. In the work, sixty mice were randomly and equally selected into six groups: normal control group (NC), normal exercise group (NE), high-fat diet group (HFD), high-fat diet plus exercise group (HFE), miR-34a overexpression group (OE), and miR-34a overexpression plus exercise group (OEE). Live morphology showed that treadmill exercise intervention for 8 weeks reduced high-fat diet-induced liver steatosis in mice. 8-week treadmill exercise directly decreased mir-34a expression of mice in HFD group, confirmed in OE group. More, treadmill exercise enhanced the expression of PPAR\u03b1 and SIRT1, thereby affecting the downstream hepatic steatosis-associated target genes, including CPT1(Carnitine palmitoyltransferase 1), CPT2(Carnitine palmitoyltransferase 2), SLC27A1(Solute carrier family 27 member 1), SLC27A4(Solute carrier family 27 member 4), in addition to activating the expression of the central metabolic sensor AMPK. Following aerobic exercise intervention, miR-34a was downregulated, thereby affecting the expression of genes associated with hepatic steatosis, and this mechanism was confirmed in miR-34a overexpression mice. This study contributed to our understanding of the pathogenesis of hepatic steatosis and may provide new therapeutic approaches.<\/jats:p>","DOI":"10.1371\/journal.pone.0333872","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:40:07Z","timestamp":1762972807000},"page":"e0333872","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aerobic exercise improved liver steatosis by modulating miR-34a-mediated PPAR\u03b1\/SIRT1-AMPK signaling pathway"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9394-8641","authenticated-orcid":true,"given":"Baoai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"1","key":"pone.0333872.ref001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"RE Castro","year":"2013","journal-title":"J Hepatol"},{"key":"pone.0333872.ref002","doi-asserted-by":"crossref","first-page":"111778","DOI":"10.1016\/j.biopha.2021.111778","article-title":"The HIF-2\u03b1\/PPAR\u03b1 pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis","volume":"140","author":"H Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"pone.0333872.ref003","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.sult.2016.08.003","article-title":"Hepatic Steatosis: Etiology, Patterns, and Quantification","volume":"37","author":"IS Idilman","year":"2016","journal-title":"Semin Ultrasound CT MR"},{"issue":"22","key":"pone.0333872.ref004","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.3390\/ijms20225547","article-title":"MicroRNAs as Potential Biomarkers in Atherosclerosis","volume":"20","author":"A Churov","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0333872.ref005","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jcp.25854","article-title":"Interplay between miRNAs and human diseases","volume":"233","author":"P Paul","year":"2018","journal-title":"J Cell Physiol"},{"issue":"8","key":"pone.0333872.ref006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/jir.2024.0059","article-title":"The Interplay Between Cytokines and MicroRNAs to Regulate Metabolic Disorders","volume":"44","author":"L Zhang","year":"2024","journal-title":"J Interferon Cytokine Res"},{"issue":"17","key":"pone.0333872.ref007","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"J Lee","year":"2010","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0333872.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"S Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"pone.0333872.ref009","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","article-title":"Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice","volume":"90","author":"IP Pogribny","year":"2010","journal-title":"Lab Invest"},{"key":"pone.0333872.ref010","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease","volume":"5","author":"J Ding","year":"2015","journal-title":"Sci Rep"},{"issue":"36","key":"pone.0333872.ref011","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"M Yamakuchi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"pone.0333872.ref012","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3390\/ijms21072391","article-title":"Hepatic Lipid Catabolism via PPAR\u03b1-Lysosomal Crosstalk","volume":"21","author":"RA Sinha","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0333872.ref013","article-title":"SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases","volume":"162","author":"CWS Hoong","year":"2021","journal-title":"Endocrinology"},{"key":"pone.0333872.ref014","doi-asserted-by":"crossref","first-page":"452061","DOI":"10.1155\/2013\/452061","article-title":"Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?","volume":"2013","author":"P Dongiovanni","year":"2013","journal-title":"PPAR Res"},{"key":"pone.0333872.ref015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0300-9084(97)81496-4","article-title":"Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism","volume":"79","author":"N Latruffe","year":"1997","journal-title":"Biochimie"},{"issue":"4","key":"pone.0333872.ref016","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dbi18-0043","article-title":"Exercise Combats Hepatic Steatosis: Potential Mechanisms and Clinical Implications","volume":"69","author":"JP Thyfault","year":"2020","journal-title":"Diabetes"},{"issue":"1","key":"pone.0333872.ref017","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial","volume":"35","author":"M Ezpeleta","year":"2023","journal-title":"Cell Metab"},{"issue":"5","key":"pone.0333872.ref018","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/mmr.2022.12841","article-title":"Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis","volume":"26","author":"K Matsumoto","year":"2022","journal-title":"Mol Med Rep"},{"issue":"8","key":"pone.0333872.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"S Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"pone.0333872.ref020","first-page":"6890423","article-title":"MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-\u03b21\/smad Pathway","volume":"2021","author":"Y Pan","year":"2021","journal-title":"J Immunol Res"},{"issue":"7353","key":"pone.0333872.ref021","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"M Trajkovski","year":"2011","journal-title":"Nature"},{"issue":"3","key":"pone.0333872.ref022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/13813455.2018.1510968","article-title":"High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats","volume":"126","author":"F Kalaki-Jouybari","year":"2020","journal-title":"Arch Physiol Biochem"},{"issue":"34","key":"pone.0333872.ref023","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.3748\/wjg.v25.i34.5120","article-title":"Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1\/AMPK and NF-\u03baB signaling pathways","volume":"25","author":"C-X Li","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"7","key":"pone.0333872.ref024","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha","volume":"26","author":"Z Gerhart-Hines","year":"2007","journal-title":"EMBO J"},{"issue":"6","key":"pone.0333872.ref025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"S-E Choi","year":"2013","journal-title":"Aging Cell"},{"issue":"3","key":"pone.0333872.ref026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0092-8674(94)90252-6","article-title":"Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein","volume":"79","author":"JE Schaffer","year":"1994","journal-title":"Cell"},{"issue":"3","key":"pone.0333872.ref027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1097-2765(00)80332-9","article-title":"Identification of the major intestinal fatty acid transport protein","volume":"4","author":"A Stahl","year":"1999","journal-title":"Mol Cell"},{"issue":"3","key":"pone.0333872.ref028","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1194\/jlr.M800400-JLR200","article-title":"Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice","volume":"50","author":"J Shim","year":"2009","journal-title":"J Lipid Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:40:11Z","timestamp":1762972811000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0333872"}},"subtitle":[],"editor":[{"given":"Jean-Marc A","family":"Lobaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0333872","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}